Company
PRESS RELEASE
TFLL Pharma Achieves Milestone with Patent Approval for Innovative Custom Supplements® Curcumin + Selenium Orodispersible Tablet Food Supplement
[Belgium and Turkiye, October 3, 2023]
TFLL Pharma a leading innovator in the field of dietary supplements, is pleased to announce a significant achievement with the recent approval of its patent application by the European Patent Office (EPO). The patent covers the groundbreaking formulation of "Custom Supplements® Curcumin+Selenium Orodispersible Tablet Food Supplement," marking a pioneering development in the industry.
Custom Supplements® Curcumin+Selenium Orodispersible Tablet Food Supplement is a unique and innovative product that combines 45 mg of curcuminoid and 37.5 mg of curcumin's active ingredients within 300 mg of turmeric root extract (Curcuma longa). This powerful formulation is further enriched with 10 micrograms of selenium, a vital mineral known for its health benefits.
The key differentiator of this remarkable product lies in its orodispersible tablet formulation. With this advanced technology, absorption of the essential nutrients begins right in the mouth, allowing for enhanced bioavailability and rapid effectiveness. This innovative approach sets Custom Supplements® Curcumin+Selenium Orodispersible Tablet Food Supplement apart from traditional supplement delivery methods.
The recent approval of the patent by the European Patent Office recognizes the groundbreaking nature of this formulation and affords TFLL Pharma exclusive rights to produce and market this product within the EPO's jurisdiction.
TFLL Pharma’s commitment to research, innovation, and quality has culminated in this significant milestone. The company is dedicated to providing consumers with cutting-edge dietary supplements that promote well-being and health.
"We are thrilled to have our formulation patent approved by the European Patent Office," said CEO, Pharmaceutical Biotechnologist Şerhan Şimşek, PhD. "This recognition reinforces our commitment to pushing the boundaries of innovation in the dietary supplement industry. Custom Supplements® Curcumin+Selenium Orodispersible Tablet Food Supplement exemplifies our dedication to providing consumers with products that are not only effective but also convenient and easy to incorporate into their daily routines."
TFLL Pharma is poised to expand the availability of Custom Supplements® Curcumin+Selenium Orodispersible Tablet Food Supplement in Europe and beyond, making this groundbreaking formulation accessible to a wider audience.
For more information about Custom Supplements® Curcumin+Selenium Orodispersible Tablet Food Supplement and other innovative products from TFLL Pharma, please visit www.tfllpharma.com
About TFLL Pharma
TFLL Pharma is a leading innovator in the field of dietary supplements, dedicated to providing cutting-edge nutritional solutions to enhance the well-being and health of consumers worldwide. With a commitment to research, quality, and innovation, TFLL Pharma continues to push the boundaries of what is possible in the dietary supplement industry.
Our supplements are made with only the highest quality ıngredients, ensuring that you receive the most effective and safe supplements possible. We are committed to keeping up-to-date with the latest research and scientific developments, and we use this knowledge to create supplements that are at the forefront of scientific innovation.
Contact: Şerhan Şimşek, PhD-CEO
Phone:
+90 216 687 09 53
+32 11 286 900
Email: info@tfllpharma.com
Website: www.tfllpharma.com